首页> 美国卫生研究院文献>The Scientific World Journal >Technological Progress in Generation of Induced Pluripotent Stem Cells for Clinical Applications
【2h】

Technological Progress in Generation of Induced Pluripotent Stem Cells for Clinical Applications

机译:临床应用诱导多能干细胞的产生技术进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is achieved by viral-mediated transduction of defined transcription factors. Generation of iPSCs is of great medical interest as they have the potential to be a source of patient-specific cells. For the eventual goal of clinical application, it is necessary to overcome the limitations of low reprogramming efficiency and chromosomal abnormalities due to viral DNA integration. In this paper, we summarize the current state of reprogramming technology for generation of iPSCs and also discuss potential approaches to the development of safe iPSCs for personalized cell-based replacement therapy.
机译:通过病毒介导的确定的转录因子转导,将体细胞重编程为诱导性多能干细胞(iPSC)。 iPSC的产生具有巨大的医学意义,因为它们有可能成为患者特异性细胞的来源。为了临床应用的最终目标,必须克服由于病毒DNA整合而导致的低重编程效率和染色体异常的局限性。在本文中,我们总结了用于生成iPSC的重编程技术的现状,并讨论了用于个性化基于细胞的替代疗法开发安全iPSC的潜在方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号